التفاصيل البيبلوغرافية
| العنوان: |
How Much Better is Faster? Empirical Tests of QALY Assumptions in Health-Outcome Sequences: Tests of Health-Outcome Sequences: F. R. Johnson et al. |
| المؤلفون: |
Johnson, F. Reed1,2 (AUTHOR), Sheehan, John J.3 (AUTHOR), Ozdemir, Semra1,2 (AUTHOR) semra.ozdemir@duke.edu, Wallace, Matthew2 (AUTHOR), Yang, Jui-Chen2 (AUTHOR) |
| المصدر: |
PharmacoEconomics. Jan2025, Vol. 43 Issue 1, p45-52. 8p. |
| مصطلحات موضوعية: |
MENTAL depression, PATIENT preferences, CONFIDENCE intervals, EXPERIMENTAL design, TREATMENT duration |
| مستخلص: |
Objectives: This study was designed to test hypotheses regarding the path dependence of health-outcome values in the form of linear additivity of health-state utilities and diminishing marginal utility of health outcomes. Methods: We employed a discrete-choice experiment to quantify patient treatment preferences for major depressive disorder. In a series of choice questions, participants evaluated seven symptom-improvement sequences and out-of-pocket costs over 6-week durations. Money-equivalent values were derived from a deductive latent-class mixed-logit analysis. Results: The discrete-choice experiment was completed by 751 respondents with self-reported major depressive disorder recruited from an online commercial panel. The class-membership probability was 0.83 for latent-class preferences consistent with supporting relative importance weights for all symptom-improvement sequences in the study design. First, we found strong support for diminishing marginal utility in symptom-improvement sequences. The money-equivalent value of an initial week of normal mood was $147 (95% confidence interval: $128, $166) and a second week of normal mood was $70 ($49, $91). Furthermore, for short treatment durations where conventional discounting was not a factor, equivalent changes in health status were valued more highly for an earlier onset of effect: holding subsequent symptom patterns constant, $338 (211, 454) versus $70 (49, 91) for improvements starting in week 2 versus week 3 and $147 ($128, $166) versus $29 (−$4, $64) for improvements starting in week 3 versus week 4. Conclusions: Our findings imply that conventional quality-adjusted life-year calculations in which health values are assumed to be path independent can understate the value of health improvements that appear earlier in a sequence. [ABSTRACT FROM AUTHOR] |
|
Copyright of PharmacoEconomics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Business Source Index |